Does Wellbutrin Cause Dry Mouth?
Yes, Wellbutrin (bupropion) commonly causes dry mouth as a dose-related adverse effect, occurring in approximately 20% of patients treated for obesity and being one of the only two adverse effects that occur significantly more frequently than placebo in smoking cessation trials.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Wellbutrin XL explicitly lists dry mouth as one of the most common side effects 1. In controlled clinical trials, dry mouth occurred at rates significantly higher than placebo, particularly at the 300 mg/day and 400 mg/day doses 1.
Frequency and Clinical Significance
Dry mouth is one of the two most consistent adverse effects of bupropion (the other being insomnia) 2. The frequency varies by indication:
- For obesity management: Dry mouth occurs in approximately 20% of patients taking bupropion 3
- For smoking cessation: Dry mouth was one of only two adverse effects that occurred significantly more commonly with bupropion versus placebo in early trials 2
- For depression: Dry mouth is listed among the most common adverse reactions across all formulations 1
Dose-Related Effect
Both dry mouth and insomnia appear to be dose-related 2. This means:
- Higher doses (300-400 mg/day) are more likely to cause dry mouth than lower doses
- The effect may improve with dose reduction
- Neither dry mouth nor insomnia is commonly a cause for drug discontinuation 2
Clinical Management Considerations
The dry mouth associated with bupropion is generally transient and often resolves without intervention 4. When it does persist:
- It can typically be managed by dose reduction if necessary 4
- The adverse effect is usually mild to moderate in severity
- It rarely leads to treatment discontinuation 2
Important Context
One case report documented oral candidiasis developing in a geriatric patient following bupropion initiation, potentially related to worsening dry mouth 5. This suggests that in vulnerable populations (particularly older adults with baseline dry mouth), the xerostomia from bupropion may predispose to secondary complications like oral fungal infections.
Compared to other antidepressants, bupropion's risk of dry mouth is notable but not exceptional. A meta-analysis found that SNRIs carry a higher risk of dry mouth (RR=2.24) compared to SSRIs (RR=1.65), while bupropion falls somewhere in this range 6.
Bottom Line for Prescribing
When prescribing Wellbutrin, counsel patients that dry mouth is a common, expected side effect that:
- Occurs in approximately 1 in 5 patients
- Is dose-dependent
- Usually improves over time
- Can be managed with dose adjustment if bothersome
- Rarely requires discontinuation
Monitor older adults more carefully for complications of xerostomia, including oral candidiasis, particularly if they have baseline dry mouth or other risk factors 5, 7.